Kawada M, Nagamori S, Aizaki H, Fukaya K, Niiya M, Matsuura T, Sujino H, Hasumura S, Shimizu K, Yoshida H
Department of Internal Medicine (I), Jikei University School of Medicine, Tokyo, Japan.
Hum Cell. 1994 Jun;7(2):95-100.
An artificial liver will be useful for the treatment of acute hepatic failure and a bridge of liver transplantation. The current reports suggest that the hybrid type of artificial liver composed of functional human liver cells and a bioreactor is practical for clinical use. In the present study, we succeeded high density culture on a large-scale of human functional hepatoma (JHH-7) using a newly developed radial flow packed-bed bioreactor. Since the shear stress of this bioreactor is lower than the other type, high density culture without cell damage is possible. JHH-7 cells produced large amounts of human albumin and other liver specific proteins, and then have the function of ammonia metabolism in the system. This study suggests that a radial flow bioreactor will be developed as a new type of artificial liver.
人工肝对于急性肝衰竭的治疗及肝移植的桥梁作用将是有益的。目前的报告表明,由功能性人肝细胞和生物反应器组成的混合型人工肝在临床上具有实际应用价值。在本研究中,我们使用新开发的径向流填充床生物反应器成功地大规模高密度培养了人功能性肝癌细胞(JHH-7)。由于该生物反应器的剪切应力低于其他类型,因此可以在不损伤细胞的情况下进行高密度培养。JHH-7细胞产生大量人白蛋白和其他肝脏特异性蛋白质,并且在该系统中具有氨代谢功能。本研究表明,径向流生物反应器将被开发成为一种新型人工肝。